# A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

> **NCT01429792** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1013 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** peginterferon alfa-2a [Pegasys]
- **DRUG:** ribavirin [Copegus]

## Key facts

- **NCT ID:** NCT01429792
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-25
- **Primary completion:** 2013-06-10
- **Final completion:** 2013-06-10
- **Target enrollment:** 1013 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429792, "A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01429792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*